🔗 Permalink

Inventor profile of:

Gregory HAIWICK

City:

Ankeny, Iowa

Country:

United States

Published Applications:

Last publication date:

2025-07-31

Top Assignees for applications by Gregory HAIWICK

The entities that hold a legal rights for patent applications filed by inventor HAIWICK Gregory:

Boehringer Ingelheim Vetmedica, Inc. 5 St. Joseph, MO United States
Boehringer Ingelheim Vetmedica, Inc. 1 Saint Joseph, MO United States

Recent patent applications by HAIWICK Gregory

Gregory HAIWICK from Ankeny, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-07-31

US20250243246A1

Chemistry; metallurgy

PCV2 ORF2 PROTEIN VARIANT AND VIRUS LIKE PARTICLES COMPOSED THEREOF

#2 | 2024-03-07

US20240076321A1

Chemistry; metallurgy

PCV2 ORF2 protein variant and virus like particles composed thereof

#3 | 2021-07-22

US20210221852A1

Chemistry; metallurgy

PCV2 ORF2 protein variant and virus like particles composed thereof

#4 | 2019-01-24

US20190023747A1

Chemistry; metallurgy

PCV2 ORF2 protein variant and virus like particles composed thereof

#5 | 2017-08-17

US20170232094A1

Human necessities

PORCINE CIRCOVIRUS TYPE 2 (PCV2) SUBUNIT VACCINE

#6 | 2017-02-02

US20170029471A1

Chemistry; metallurgy

PCV2 ORF2 protein variant and virus like particles composed thereof

#7 | 2016-07-21

US20160206727A1

Human necessities

ORF2 PROTEIN OF PCV2 SUBTYPE A (PCV2A) FOR USE IN CROSS-PROTECTION

#8 | 2015-04-02

US20150093404A1

Chemistry; metallurgy

PCV2 ORF2 protein variant and virus like particles composed thereof

#9 | 2015-02-26

US20150056248A1

Human necessities

PORCINE CIRCOVIRUS TYPE 2 (PCV2) SUBUNIT VACCINE

#10 | 2014-10-30

US20140322267A1

Human necessities

ORF2 PROTEIN OF PCV2 SUBTYPE A (PCV2A) FOR USE IN CROSS-PROTECTION

#11 | 2011-03-10

US20110059126A1

Human necessities

Methods of reducing virucidal activity in PCV-2 compositions and PCV-2 compositions with an improved immunogenicity

InventorID:

952789 ⎘